P-Aminobenzoic Acid Manufacturing Process High Purity Coa

• [Reaction Engineering]: Optimized catalytic hydrogenation and biocatalytic routes ensure yields exceeding 99% purity with controlled crystal modification.
• [Sourcing Integrity]: Factory direct procurement guarantees stable supply chains for tonnage quantities of Vitamin Bx derivatives.
• [Compliance Metrics]: Rigorous COA verification and impurity profiling meet global regulatory standards for pharmaceutical intermediates.

The production of p-Aminobenzoic Acid (CAS: 150-13-0) requires precise control over reaction kinetics and crystallization parameters to meet the demanding specifications of the pharmaceutical and dye industries. As a critical Benzocaine Intermediate and Procainamide Precursor, the material must possess consistent industrial purity and minimal impurity profiles. At NINGBO INNO PHARMCHEM CO.,LTD., we leverage advanced chemical engineering to deliver batch-to-batch consistency essential for downstream synthesis.

Optimizing Synthesis Routes for Maximum Yield

Understanding the synthesis route is vital for R&D teams evaluating raw material compatibility. Historically, two primary methodologies dominate the market: catalytic hydrogenation of nitro precursors and modern fermentative processes. In the hydrogenation pathway, p-nitrobenzoic acid salts are reduced under controlled pressure (100–600 psig) and temperature (80–120°C) using noble metal catalysts such as palladium on carbon. Maintaining a pH range of 7.0 to 7.5 during reduction is critical to prevent the formation of azo and hydrazo byproducts, which can discolor the final product and complicate purification.

Alternatively, biocatalytic routes utilize recombinant microorganisms to accumulate aminobenzoates in fermentation broth. The isolation step here relies on a one-step acid treatment, typically adjusting the pH to the isoelectric point between 3.4 and 3.6. This precise acidification promotes the crystallization of Modification I, which offers superior stability and lower solubility compared to Modification II. Whether sourcing chemically synthesized or bio-based 4-Carboxyaniline, buyers must verify the crystal form and residual solvent content to ensure compatibility with their specific manufacturing process.

Ensuring High Purity Standards and Impurity Control

Achieving high purity extends beyond the primary reaction; it requires robust downstream processing. Residual nitro compounds, heavy metals from catalysts, and ash content are key parameters monitored during quality control. Advanced crystallization techniques, such as forced circulation crystallizers with elutriators, allow for the growth of uniform crystal sizes (e.g., 200–400 µm). This uniformity facilitates efficient filtration and washing, reducing mother liquor entrapment and minimizing ash content to below 0.05%.

For pharmaceutical applications, the limit for related substances is strictly enforced. High-performance liquid chromatography (HPLC) is employed to detect trace isomers and degradation products. When sourcing high-purity 4-Aminobenzoic Acid, procurement officers should request detailed impurity profiles alongside the Certificate of Analysis. This data confirms that the material meets the stringent requirements for use as Vitamin Bx or in sensitive coupling reactions.

Procurement Stability and Documentation

For procurement specialists and executives, supply chain reliability is as critical as chemical specifications. Securing a factory direct partnership eliminates intermediary markups and ensures transparency regarding bulk price fluctuations. A global manufacturer with integrated production capabilities can offer a stable supply even during raw material shortages. Furthermore, regulatory compliance regarding REACH and TSCA is mandatory for international shipment.

Documentation such as the COA (Certificate of Analysis), SDS (Safety Data Sheet), and method validation reports must be batch-specific. Executives should verify that the supplier maintains ISO-certified quality management systems to guarantee commercial viability and risk mitigation. NINGBO INNO PHARMCHEM CO.,LTD. supports partners with comprehensive technical dossiers that streamline vendor qualification audits.

Parameter	Specification	Test Method
Assay (HPLC)	≥ 99.0%	Internal QC / USP
Loss on Drying	≤ 0.5%	Karl Fischer / Oven
Residue on Ignition (Ash)	≤ 0.1%	Gravimetric
p-Nitrobenzoic Acid (Residual)	≤ 0.05%	HPLC
Heavy Metals	≤ 10 ppm	ICP-MS
Crystal Form	Modification I	XRD / DSC

To ensure your production lines remain operational with premium grade intermediates, we invite you to contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote. Our experts are ready to discuss custom synthesis options and logistical requirements tailored to your facility.